Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 4Phase 1/2 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 4Unknown 3Completed 3Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Carcinoma, Non-Small-Cell Lung 173Leukemia, Myeloid, Acute 152Breast Neoplasms 146Neoplasms 143Neoplasm Metastasis 142Colorectal Neoplasms 137Recurrence 105Ovarian Neoplasms 101Pancreatic Neoplasms 83Advanced Solid Tumor 82Lung Neoplasms 81Multiple Myeloma 77Prostatic Neoplasms 75Advanced Solid Tumors 74Stomach Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Carcinoma, Hepatocellular 68Glioblastoma 65Melanoma 64Lymphoma, Non-Hodgkin 64Triple Negative Breast Neoplasms 59Lymphoma, B-Cell 55Endometrial Neoplasms 54Myelodysplastic Syndromes 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Lymphoma 52Glioma 51Brain Neoplasms 46Carcinoma, Renal Cell 44Hematologic Neoplasms 43

Interventions

fludarabine phosphate 1fludarabine 1darolutamide 1cabozantinib 1Pluvicto 1Cyclophosphamide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT06492122 2026-05-26

ProTACT

Full-Life Technologies GmbH

Phase 1 Recruiting
50 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07244341 2026-05-15

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Daiichi Sankyo

Phase 1 Recruiting
60 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06193486 2026-03-31

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
30 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05613894 2025-10-31

CaboLu

University of Utah

Phase 1 Recruiting
33 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡